GlassScriptPhysician profile
Kimberly Lynn Bain
NPI 1073057683
$2,505.86
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,034 · 2022: $357 · 2023: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595 · Travel and Lodging: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.69 |
| Travel and Lodging | $519.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,151.58 | 2022-2023 | |
| Seagen INC. | $300.10 | 2021-2023 | Adcetris |
| Puma Biotechnology, INC. | $142.51 | 2021 | |
| Boston Scientific Corporation | $107.05 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2022 | |
| Lilly USA, LLC | $94.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $89.71 | 2021-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $70.04 | 2021-2023 | |
| Janssen Biotech, INC. | $60.99 | 2021 | |
| Daiichi Sankyo INC. | $56.67 | 2021 | |
| Amgen INC. | $50.35 | 2021 | |
| Astellas Pharma US INC | $38.53 | 2021 | |
| Incyte Corporation | $35.98 | 2021 | |
| Eisai INC. | $32.13 | 2021 | |
| Pfizer INC. | $23.07 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $22.49 | 2021 | |
| Celgene Corporation | $20.74 | 2021 | |
| Merck Sharp & Dohme LLC | $17.57 | 2021 | |
| Abbott Laboratories | $16.48 | 2023 | Cardiomems |
| Heron Therapeutics, INC. | $16.05 | 2021 | |
| Tersera Therapeutics LLC | $15.40 | 2021 | |
| Genzyme Corporation | $14.99 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.85 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $14.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Bain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.